Acro Biomedical (ACBM) Net Cash Flow (2015 - 2025)
Acro Biomedical (ACBM) recorded quarterly Net Cash Flow of -$225.0 in Q4 2025, down 105.24% quarter-over-quarter from $4297.0 in Q3 2025, and little changed on a YoY basis from -$225.0 in Q4 2024.
Acro Biomedical (ACBM) Net Cash Flow (2015 - 2025) Analysis & Trends
Acro Biomedical's Net Cash Flow history runs 11 years deep, the most recent figure standing at -$225.0 for Q4 2025.
- In Q4 2025, Net Cash Flow changed 0.0% year-over-year to -$225.0; the TTM figure through Dec 2025 stood at $3622.0 (up 3522.0% YoY), while the FY2025 annual figure was $3622.0, up 3522.0% from the prior year.
- Net Cash Flow was -$225.0 for Q4 2025 at Acro Biomedical, down from $4297.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $262420.0 in Q1 2022 to a low of -$345561.0 in Q2 2022.
- Historically, Net Cash Flow has averaged -$701.25 across 5 years, with a median of -$225.0 in 2024.
- The sharpest annual moves came in 2021 and 2022: Net Cash Flow tumbled 26936.0% in 2021, then jumped 4108.15% in 2022.
- A 5-year view of Net Cash Flow shows it stood at -$59415.0 in 2021, then jumped by 82.6% to -$10336.0 in 2022, then soared by 71.99% to -$2895.0 in 2023, then jumped by 92.23% to -$225.0 in 2024, then changed by 0.0% to -$225.0 in 2025.
- The last three Net Cash Flow figures came in at -$225.0 (Q4 2025), $4297.0 (Q3 2025), and -$225.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 378,972.00 |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -32,793.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -369,667.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 165,329.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -72,157.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -208,889.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -16.06 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 328,760.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -204,942.00 |
| 10 | Acro Biomedical | - | - | - | -225.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -225.00 |
| Dec 31, 2025 | -225.00 |
| Sep 30, 2025 | 4,297.00 |
| Sep 30, 2025 | 4,297.00 |
| Jun 30, 2025 | -225.00 |
| Jun 30, 2025 | -225.00 |
| Mar 31, 2025 | -225.00 |
| Mar 31, 2025 | -225.00 |
| Dec 31, 2024 | -225.00 |
| Dec 31, 2024 | -225.00 |
| Sep 30, 2024 | -225.00 |
| Sep 30, 2024 | -225.00 |
| Jun 30, 2024 | 775.00 |
| Jun 30, 2024 | 775.00 |
| Mar 31, 2024 | -225.00 |
| Mar 31, 2024 | -225.00 |
| Dec 31, 2023 | -2,895.00 |
| Dec 31, 2023 | -2,895.00 |
| Sep 30, 2023 | 591.00 |
| Sep 30, 2023 | 591.00 |